How to Recognise Financial Mis-Selling and Assured-Return Claims

Nobody lied to Lakshmi

Lakshmi was sold a product at her bank, by an official she has dealt with for eleven years, in the branch where her retirement money already sits. It was described as safe, as giving her a regular payout, and as being better than what she currently held.

Every one of those statements was defensible. It is a real product from a real institution, the document discloses the charges, and the illustration is labelled as an illustration. Nobody said anything provably false.

She still ended up with something that locks money away for longer than she expects to need it, pays her less than she believed, and would cost her a substantial portion of what she put in if she wanted out in the first few years. She did not read the paperwork closely, and the paperwork was accurate.

That is what mis-selling usually looks like, and it is why "read the documents" is insufficient advice. The documents are generally fine. The gap is between the document and the conversation, and the conversation is where the sale happens.

The claim that ends the discussion

If a market-linked investment is described as assured, guaranteed or risk-free, the conversation is over.

Returns from market investments cannot be guaranteed. Where a product genuinely does guarantee something — and certain insurance and deposit products do — the guarantee is narrow, defined precisely in the contract, and usually much less generous than the number being discussed. The word "guaranteed" attached to a projection, an illustration or an equity-linked return misdescribes the product regardless of who is saying it.

The softer forms are more common and do the same work. "Historically it has always given around" is a description of the past presented as a floor. "Capital protected" is sometimes a real feature and often a phrase used loosely — ask what protects it, who is obliged to pay, and under what conditions the protection fails. "Assured bonus" or "guaranteed addition" may refer to a component calculated on a base much smaller than the amount you actually pay. And "zero risk" applied to anything that is not a sovereign obligation is simply wrong.

One question settles all of them: who is contractually obliged to pay this, and what happens if they do not? If there is no answer naming an entity and a clause, there is no guarantee.

The patterns worth recognising

Insurance sold as investment is the most widespread form in India and the one Lakshmi met. Products combining life cover with an investment component are typically worse at both jobs than buying term insurance and investing separately would be, while carrying charges that are hard to see. The sale is usually framed around returns and tax with the cover mentioned as a bonus, which inverts what the product mainly is.

The deadline is the next pattern. Sales cluster at the end of the tax year, when urgency can be attributed to a date rather than to the seller, and a product bought to meet a deadline is a product chosen without comparison. That is the entire point of the timing.

Then there is the illustration read as a forecast. Illustrations often show more than one growth scenario because the rules require it, and in conversation the higher one quietly becomes "what you will get". Ask which assumption produced the figure being discussed, and ask to see the lower one.

Watch for a long commitment introduced late — a product requiring payments for many years, where stopping early is heavily penalised, presented as though the commitment were incidental. Ask explicitly what happens if you stop after two years, because the surrender value is where unsuitability becomes visible.

The switch is a quieter one: being advised to exit an existing product and enter a similar one. There is sometimes a genuine reason, and there is always a payment to whoever arranges it, so ask what specifically is better, in numbers, net of exit and entry costs. And the relationship sale is the hardest to defend against, because the setting supplies the trust the product has not earned — which is exactly how a bank official Lakshmi has known for a decade sold her something she would have questioned from a stranger.

Finally, treat complexity as a signal. If a product takes twenty minutes to explain and you still could not describe it to somebody else, that is not sophistication. Complexity is where charges hide, because it defeats comparison.

The questions that expose it

Ask these, and ask for the answers in writing, because the reaction is often more informative than the reply.

What exactly am I buying — insurance, investment, or both, and if both, why should they be bought together rather than separately? What are all the charges, every year, as an amount rather than a headline rate? What do I receive if I stop after one year, and after three? What is the worst outcome this contract permits, since every product has one? Which number here is contractually guaranteed and which is an illustration? How are you paid, and what would you receive if I bought the cheaper alternative instead? And what is the cheaper alternative, because everything has one and an adviser unwilling to name it has told you something.

Protecting yourself structurally

Never buy at the meeting. Applied without exception, that one rule prevents most mis-selling, because pressure cannot survive a delay — take the documents home and decide later.

Buy insurance and investments separately unless you can articulate why combining them is better for you specifically. Ask for anything important in writing, since verbal assurances that are not in the document do not exist. Check the entity rather than the person, verifying registration with the regulator directly, and never transfer money to an individual or to an account not in the institution's name. And take a second opinion on anything carrying a long lock-in — somebody with nothing to gain from the decision, even a knowledgeable friend, catches most of it.

If it has already happened

Do not treat the loss as settled. Products have free-look and cancellation windows, and whether one applies depends on the product and how long ago it was bought, so check the contract and the regulator's guidance rather than assuming the door has closed.

Write down what you were told, by whom, and when, while you still remember. Complaints turn on the gap between the conversation and the document, and that gap exists only in your record of it.

Complain in writing to the institution and escalate through the formal grievance route for that sector if you are not satisfied. India has ombudsman and complaint mechanisms for insurance, banking and securities, and which one applies depends on the product, so identify the right forum before writing.

And be careful about the decision to exit, because surrendering some products crystallises the worst of the loss and the right answer is occasionally to keep a bad product rather than pay to leave it. Work out the numbers before acting on the anger.

What to take away

Mis-selling is usually accurate description with the wrong emphasis, sold to the wrong person, under time pressure. The document is rarely the problem; the conversation is.

Treat "assured", "guaranteed" and "risk-free" on a market-linked product as the end of the discussion. Ask what the charges are in rupees, what you get back if you stop early, and what the cheaper alternative is. And never buy in the room — nearly every version of this depends on you deciding before you have had time to compare.